The U.S. breast imaging systems market will see modest growth over the next three years, going from $1 billion in 2011 to $1.4 billion in 2016, according to market research firm Frost & Sullivan.
The anticipated growth is due to increasing revenues in the x-ray mammography, breast ultrasound, breast MRI, and molecular breast imaging market segments, Frost & Sullivan said.
Fewer breast imaging facilities in the U.S., as well as continued debate surrounding breast cancer screening, has suppressed growth in the market, according to the report. In fact, the number of U.S. breast imaging facilities declined by nearly 7% from 2002 to 2011, resulting in an even greater decline in the mammography system installed base, the company said.













![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





